<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[13, 17] high-dose interferon<br>[144, 151] high-dose IFN-alpha 2b<br>[155, 156] Obs<br>[323, 324] HDI<br></td>
<td width=33%>
[12, 17] adjuvant high-dose interferon<br>[52, 62] adjuvant high-dose IFN-alpha 2b therapy.<br>[144, 156] high-dose IFN-alpha 2b (HDI) or Obs<br>[247, 248] HDI<br>[296, 297] HDI<br>[323, 324] HDI<br></td>
<td width=33%>
[12, 17] adjuvant high-dose interferon<br>[52, 62] adjuvant high-dose IFN-alpha 2b therapy.<br>[144, 156] high-dose IFN-alpha 2b (HDI) or Obs<br>[247, 251] HDI versus Obs.<br>[296, 299] HDI versus Obs<br>[323, 328] HDI is effective adjuvant therapy<br></td>
</tr>
